SEC Form D · filed January 26, 2017
Matinas BioPharma Holdings, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (25)
Douglas F. Kling · Bedminster, NJExecAdam A. Stern · Bedminster, NJDirectorGary A. Gaglione · Bedminster, NJExecRoelof Rongen · Bedminster, NJExec · DirectorAbdel A. Fawzy · Bedminster, NJExecJerome A. Jabbour · Bedminster, NJExecStefano A. Ferrari · Bedminster, NJDirectorHerbert A. Conrad · Bedminster, NJDirectorJames F. Scibetta · Bedminster, NJDirectorRaphael J. Mannino · Bedminster, NJExecCapital Management LLC Glenville · Greenwich, CTDirectorBrook T. Byers · Menlo Park, CAExecJay Leon · Seattle, WAExec · DirectorSean Dalton · Boston, MAExecAdam D. Egelberg · Greenwich, CTExecEllen Rubin · Boston, MAExec · DirectorPaula Long · Boston, MADirectorJitendra Saxena · Boston, MAExec · DirectorDavid Orfao · Boston, MAExec · DirectorLazarus Vekiarides · Boston, MAExec · DirectorMantford C. Hawkins · Fort Worth, TXDirectorRay A. Smith · Irvine, CAExecMing Shan · Menlo Park, CADirectorXuecheng Jin · Menlo Park, CAExecQiang Li · PALO ALTO, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗